See How PENTASA Works

Moisture-activated PENTASA is a controlled-release oral 5-ASA therapy that reliably delivers mesalamine throughout the small and large intestine.2

Watch the video below to see how PENTASA works and the benefits it provides.

To view this program, you need a free plug-in called Macromedia Flash Player 8 installed on your computer. To download and install Flash, click the button.

Important Safety Information

  • PENTASA is indicated for the induction of remission and for the treatment of patients with mildly to moderately active ulcerative colitis.
  • PENTASA is generally well tolerated. In worldwide clinical trials (N>2100), the most common adverse events were diarrhea (3.4%), headache (2.0%), nausea (1.8%), abdominal pain (1.7%), dyspepsia (1.6%), vomiting (1.5%), and rash (1.0%). As with other mesalamine products, serious adverse events may occur. PENTASA is contraindicated in patients with a hypersensitivity to salicylates. Caution should be used in patients with impaired hepatic or renal function. Patients with pre-existing renal disease, increased BUN or serum creatinine, or proteinuria should be monitored during PENTASA therapy.